West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 60,900 | 143,600 | 104,500 | 66,900 | 22,100 |
| Depreciation Amortization | 23,300 | 90,700 | 67,900 | 45,000 | 22,300 |
| Income taxes - deferred | N/A | 21,500 | N/A | N/A | N/A |
| Accounts receivable | N/A | -23,300 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 6,100 | N/A | N/A | N/A |
| Other Working Capital | -67,000 | -58,700 | -54,800 | -60,500 | -60,000 |
| Other Operating Activity | 3,500 | 39,500 | 30,000 | 27,800 | 18,600 |
| Operating Cash Flow | $20,700 | $219,400 | $147,600 | $79,200 | $3,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -37,500 | -170,200 | -122,700 | -74,000 | -39,000 |
| Purchase Of Investment | N/A | -8,400 | -8,400 | -8,400 | N/A |
| Other Investing Activity | 2,800 | 2,800 | 2,000 | 1,200 | 400 |
| Investing Cash Flow | $-34,700 | $-175,800 | $-129,100 | $-81,200 | $-38,600 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -600 | -69,800 | -69,200 | -68,600 | -68,000 |
| Common Stock Issued | 19,100 | 29,700 | 24,600 | 21,400 | 13,400 |
| Common Stock Repurchased | -30,700 | -55,900 | -30,500 | -20,900 | -12,800 |
| Dividend Paid | -9,500 | -35,800 | -26,200 | -17,500 | -8,700 |
| Other Financing Activity | -100 | 17,900 | 13,800 | 13,100 | 11,000 |
| Financing Cash Flow | $-21,800 | $-113,900 | $-87,500 | $-72,500 | $-65,100 |
| Exchange Rate Effect | 2,200 | -1,300 | 300 | 2,600 | 4,200 |
| Beginning Cash Position | 203,000 | 274,600 | 274,600 | 274,600 | 274,600 |
| End Cash Position | 169,400 | 203,000 | 205,900 | 202,700 | 178,100 |
| Net Cash Flow | $-33,600 | $-71,600 | $-68,700 | $-71,900 | $-96,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,700 | 219,400 | 147,600 | 79,200 | 3,000 |
| Capital Expenditure | -37,500 | -170,200 | -122,700 | -74,000 | -39,000 |
| Free Cash Flow | -16,800 | 49,200 | 24,900 | 5,200 | -36,000 |